English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/61362
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Neuroprotective Effects of Progesterone in Chronic Experimental Autoimmune Encephalomyelitis

AuthorsGiatti, S.; Caruso, D.; Boraso, M.; Abbiati, F.; Ballarini, E.; Calabrese, D.; Pesaresi, M.; Rigolio, Roberta; Santos-Galindo, María ; Viviani, Bárbara; Cavaletti, G.; García-Segura, Luis M. ; Melcangi, R. C.
Issue Date2012
PublisherBlackwell Publishing
CitationJournal of Neuroendocrinology 24: 851- 861 (2012)
AbstractObservations so far obtained in experimental autoimmune encephalomyelitis (EAE) have revealed the promising neuroprotective effects exerted by progesterone (PROG). The findings suggest that this neuroactive steroid may potentially represent a therapeutic tool for multiple sclerosis (MS). However, up to now, the efficacy of PROG has been only tested in the acute phase of the disease, whereas it is well known that MS expresses different features depending on the phase of the disease. Accordingly, we have evaluated the effect of PROG treatment in EAE induced in Dark Agouti rats (i.e. an experimental model showing a protracted relapsing EAE). Data obtained 45days after EAE induction show that PROG treatment exerts a beneficial effect on clinical score, confirming surrogate parameters of spinal cord damage in chronic EAE (i.e. reactive microglia, cytokine levels, activity of the Na +,K +-ATPase pump and myelin basic protein expression). An increase of the levels of dihydroprogesterone and isopregnanolone (i.e. two PROG metabolites) was also observed in the spinal cord after PROG treatment. Taken together, these results indicate that PROG is effective in reducing the severity of chronic EAE and, consequently, may have potential with respect to MS treatment. © 2012 The Authors. Journal of Neuroendocrinology © 2012 Blackwell Publishing Ltd.
URIhttp://hdl.handle.net/10261/61362
DOI10.1111/j.1365-2826.2012.02284.x
Identifiersdoi: 10.1111/j.1365-2826.2012.02284.x
issn: 0953-8194
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.